[1] 刘蓓菁. 药物心脏毒性反应与药物警戒[J]. 药物流行病学杂志, 2011, 20(4):205-208. [2] ICH. ICH Guidance for Industry ICH S7A: Safety pharmacology studies for human pharmaceut-icals [EB/OL]. (2000-11-08)[2019-10-28].http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelin-es/Safety/S7A/Step4/S7A_Guideline. pdf. [3] ICH. ICH Guidance for Industry ICH S7B: The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals [EB/OL]. (2005-05-12)[2019-10-28].http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S7B/Step4/S7B_ Guideline.pdf. [4] 陈高建, 黄芝瑛, 王三龙, 等. 诱导多能干细胞分化的心肌细胞在心脏毒性评价中的应用[J]. 药物分析杂志, 2018, 38(5):758-764. [5] Jonsson MKB, Wang QD, Becker B.Impedance-Based Detection of Beating Rhythm and Proarrhythmic Effects of Compounds on Stem Cell-Derived Cardiomyocytes[J]. Assay Drug Dev Technol, 2011, 9(6):589-599. [6] 胡碧君. 氟喹诺酮类药物不良反应分析[J]. 海峡药学, 2018, 30(12):280-281. [7] 国家药品监督管理局. 总局关于修订全身用氟喹诺酮类药品说明书的公告[EB/OL]. (2017-07-05)[2019-10-28].http://www.nmpa.gov.cn/WS04/CL2115/286700.html. [8] Zhou P, Wu FJ, Zhou TC, et al.Simple and versatile synthetic polydopamine-based surface supports reprogramming of human somatic cells and long-term self-renewal of human pluripotent stem cells under defined conditions[J]. Biomaterials, 2016, 5(87):1-17. [9] 张真真, 王三龙, 赵亚,等. 人胚胎干细胞分化的心肌细胞心脏毒性评价模型的建立及应用[J]. 中国新药杂志, 2017, 26(7):795-803. [10] Selzer A, Wray HW.Quinidine Syncope: Paroxysmal Ventricular Fibrillation Occurring during Treatment of Chronic Atrial Arrhythmias[J]. Circulation, 1964, 30(1):17-26. [11] 张婧, 王金华, 刘璐,等. 65例β-内酰胺类药物致心血管不良反应的文献分析[J].中国药物警戒, 2013, 10(4):238-241. [12] Li M, Ramos LG.Drug-Induced QT Prolongation and Torsades de Pointes[J]. P&T, 2017, 42(7):473-477. [13] 杨倩, 汪小涧, 尤启冬.药物心脏毒副作用及其产生机制与防治策略[J].中国药师, 2008, 11(6):641-643. [14] Somasundaram S, Manivannan K.An Overview of Fluoroquinolones[J]. Annual Review & Research in Biology, 2013, 3(3):296-313. [15] 谭莉莉. 喹诺酮类抗菌药物的临床不良反应[J]. 中国药物警戒, 2013, 10(2):92-95. [16] Noel GJ, Natarajan J, Chien S, et al.Effects of three fluoroquinol ones on QT interval in healthy adults after single doses[J]. Clinical Pharmacology & Therapeutics, 2003, 73(4):292-303. [17] Wilhelm H, Frank K, Anna F, et al.Update on the Cardiac Safety of Moxifloxacin[J]. Current Drug Safety, 2012, 7(2):149-163. [18] Giovanni BM, Emanuele P, Giovanni S, et al.Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review[J]. International Journal of Molecular Science, 2017,18(2):341-350. [19] Yang YY, Shen NS, Shi FW, et al.Liensinine- and Neferine-Induced Cardiotoxicity in Primary Neonatal Rat Cardiomyocytes and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes[J]. International Journal of Molecular Sciences, 2016, 17(2):186-199. |